Global perspectives on observing ocean boundary current systems

Ocean boundary current systems are key components of the climate system, are home to highly productive ecosystems, and have numerous societal impacts. Establishment of a global network of boundary current observing systems is a critical part of ongoing development of the Global Ocean Observing System. The characteristics of boundary current systems are reviewed, focusing on scientific and societal motivations for sustained observing. Techniques currently used to observe boundary current systems are reviewed, followed by a census of the current state of boundary current observing systems globally. Next steps in the development of boundary current observing systems are considered, leading to several specific recommendations

Phase Behavior of Aqueous Na-K-Mg-Ca-CI-NO3 Mixtures: Isopiestic Measurements and Thermodynamic Modeling

A comprehensive model has been established for calculating thermodynamic properties of multicomponent aqueous systems containing the Na{sup +}, K{sup +}, Mg{sup 2+}, Ca{sup 2+}, Cl{sup -}, and NO{sub 3}{sup -} ions. The thermodynamic framework is based on a previously developed model for mixed-solvent electrolyte solutions. The framework has been designed to reproduce the properties of salt solutions at temperatures ranging from the freezing point to 300 C and concentrations ranging from infinite dilution to the fused salt limit. The model has been parameterized using a combination of an extensive literature database and new isopiestic measurements for thirteen salt mixtures at 140 C. The measurements have been performed using Oak Ridge National Laboratory's (ORNL) previously designed gravimetric isopiestic apparatus, which makes it possible to detect solid phase precipitation. Water activities are reported for mixtures with a fixed ratio of salts as a function of the total apparent salt mole fraction. The isopiestic measurements reported here simultaneously reflect two fundamental properties of the system, i.e., the activity of water as a function of solution concentration and the occurrence of solid-liquid transitions. The thermodynamic model accurately reproduces the new isopiestic data as well as literature data for binary, ternary and higher-order subsystems. Because of its high accuracy in calculating vapor-liquid and solid-liquid equilibria, the model is suitable for studying deliquescence behavior of multicomponent salt systems

Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Background: In this study, we aimed to evaluate the effects of tocilizumab in adult patients admitted to hospital with COVID-19 with both hypoxia and systemic inflammation. Methods: This randomised, controlled, open-label, platform trial (Randomised Evaluation of COVID-19 Therapy [RECOVERY]), is assessing several possible treatments in patients hospitalised with COVID-19 in the UK. Those trial participants with hypoxia (oxygen saturation <92% on air or requiring oxygen therapy) and evidence of systemic inflammation (C-reactive protein ≥75 mg/L) were eligible for random assignment in a 1:1 ratio to usual standard of care alone versus usual standard of care plus tocilizumab at a dose of 400 mg–800 mg (depending on weight) given intravenously. A second dose could be given 12–24 h later if the patient's condition had not improved. The primary outcome was 28-day mortality, assessed in the intention-to-treat population. The trial is registered with ISRCTN (50189673) and ClinicalTrials.gov (NCT04381936). Findings: Between April 23, 2020, and Jan 24, 2021, 4116 adults of 21 550 patients enrolled into the RECOVERY trial were included in the assessment of tocilizumab, including 3385 (82%) patients receiving systemic corticosteroids. Overall, 621 (31%) of the 2022 patients allocated tocilizumab and 729 (35%) of the 2094 patients allocated to usual care died within 28 days (rate ratio 0·85; 95% CI 0·76–0·94; p=0·0028). Consistent results were seen in all prespecified subgroups of patients, including those receiving systemic corticosteroids. Patients allocated to tocilizumab were more likely to be discharged from hospital within 28 days (57% vs 50%; rate ratio 1·22; 1·12–1·33; p<0·0001). Among those not receiving invasive mechanical ventilation at baseline, patients allocated tocilizumab were less likely to reach the composite endpoint of invasive mechanical ventilation or death (35% vs 42%; risk ratio 0·84; 95% CI 0·77–0·92; p<0·0001). Interpretation: In hospitalised COVID-19 patients with hypoxia and systemic inflammation, tocilizumab improved survival and other clinical outcomes. These benefits were seen regardless of the amount of respiratory support and were additional to the benefits of systemic corticosteroids. Funding: UK Research and Innovation (Medical Research Council) and National Institute of Health Research

Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial

Background: Many patients with COVID-19 have been treated with plasma containing anti-SARS-CoV-2 antibodies. We aimed to evaluate the safety and efficacy of convalescent plasma therapy in patients admitted to hospital with COVID-19. Methods: This randomised, controlled, open-label, platform trial (Randomised Evaluation of COVID-19 Therapy [RECOVERY]) is assessing several possible treatments in patients hospitalised with COVID-19 in the UK. The trial is underway at 177 NHS hospitals from across the UK. Eligible and consenting patients were randomly assigned (1:1) to receive either usual care alone (usual care group) or usual care plus high-titre convalescent plasma (convalescent plasma group). The primary outcome was 28-day mortality, analysed on an intention-to-treat basis. The trial is registered with ISRCTN, 50189673, and ClinicalTrials.gov, NCT04381936. Findings: Between May 28, 2020, and Jan 15, 2021, 11558 (71%) of 16287 patients enrolled in RECOVERY were eligible to receive convalescent plasma and were assigned to either the convalescent plasma group or the usual care group. There was no significant difference in 28-day mortality between the two groups: 1399 (24%) of 5795 patients in the convalescent plasma group and 1408 (24%) of 5763 patients in the usual care group died within 28 days (rate ratio 1·00, 95% CI 0·93–1·07; p=0·95). The 28-day mortality rate ratio was similar in all prespecified subgroups of patients, including in those patients without detectable SARS-CoV-2 antibodies at randomisation. Allocation to convalescent plasma had no significant effect on the proportion of patients discharged from hospital within 28 days (3832 [66%] patients in the convalescent plasma group vs 3822 [66%] patients in the usual care group; rate ratio 0·99, 95% CI 0·94–1·03; p=0·57). Among those not on invasive mechanical ventilation at randomisation, there was no significant difference in the proportion of patients meeting the composite endpoint of progression to invasive mechanical ventilation or death (1568 [29%] of 5493 patients in the convalescent plasma group vs 1568 [29%] of 5448 patients in the usual care group; rate ratio 0·99, 95% CI 0·93–1·05; p=0·79). Interpretation: In patients hospitalised with COVID-19, high-titre convalescent plasma did not improve survival or other prespecified clinical outcomes. Funding: UK Research and Innovation (Medical Research Council) and National Institute of Health Research

Cricket's regional identities: the development of cricket and identity in Yorkshire and Surrey

Cricket literature, and that of English society generally, has attributed almost diametrically opposite regional identities to the counties, players and supporters of Yorkshire and Surrey County Cricket Clubs. This essay aims to reveal the causal factors in the development of these identities, establish the extent to which they are 'real' or 'imagined' and discover if the stereotypes presented have any contemporary relevance. The essay utilizes a survey of 400 supporters to establish the different regional meanings for cricket and to test the perceived identities or stereotypes of the two counties. A comparative analysis of the historical development and control of cricket in each county, literary representations and wider social contexts are then used to establish the various reasons for differences in the regional meaning of cricket. The essay concludes that regional differences in the development and control of the game, its image and presentation have been critical to the development of these cricket identities and cricket's meaning or function for contemporary supporters - particularly in Yorkshire. It goes on to suggest that certain myths have been advocated by social scientists and that a more 'orally historical' approach may help in the explanation of identities previously thought to represent either 'commonality' or indeed 'difference'

Biogeographical implications of a new mouse-sized fossil bandicoot (Marsupialia: Peramelemorphia) occupying a dasyurid-like ecological niche across Australia

We describe Bulungu palara gen. et sp. nov., a new fossil peramelemorphian (bandicoot), based on a single well-preserved skull and additional dental specimens from Late Oligocene to Middle Miocene (Faunal Zones A-C) limestone deposits at the Riversleigh World Heritage Property, Queensland, and two dental specimens from the Early-Middle Miocene Kutjamarpu Local Fauna, South Australia. This is the first fossil peramelemorphian species to be reported from more than a single fossil fauna, with its inferred distribution extending from north-western Queensland (modern latitude ∼19°S) to north-eastern South Australia (modern latitude ∼28°S). The presence of Bulungu palara in Riversleigh Faunal Zones A, B and C and in the Kutjamarpu Local Fauna supports the current interpretation that these faunas span similar ages, namely Late Oligocene-Middle Miocene. Phylogenetic analyses of an expanded 74 morphological character dataset using maximum parsimony and Bayesian approaches, both with and without a molecular scaffold, consistently place Bulungu and the Oligo-Miocene forms Galadi and Yarala outside crown-group Peramelemorphia. These analyses also fail to support a close relationship between the Pliocene Ischnodon australis (previously considered the oldest known representative of the extant peramelemorphian family Thylacomyidae) and the modern thylacomyid genus Macrotis. With an estimated body mass of ∼130 g, Bulungu palara is smaller than any known Recent bandicoot from Australia, although some modern New Guinean species are similar in size. The small size and craniodental morphology of B. palara suggest that it was predominantly or exclusively insectivorous, perhaps ecologically similar to small New Guinean dasyurids such as Murexechinus melanurus. Together with the small-bodied (< 100 g), insectivorous Yarala burchfieldi and large-bodied (∼900 g), faunivorous Galadi speciosus, Bulungu palara demonstrates that Oligo-Miocene Australian peramelemorphians filled ecological niches that today are mostly occupied by dasyurids, and that a major faunal turnover event occurred at some point after the Middle Miocene